Gerber Kawasaki Wealth & Investment Management Bluebird Bio, Inc. Transaction History

Gerber Kawasaki Wealth & Investment Management

$2.16 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 11, 2022	SELL	$8.96 - $16.31 $3,584 - $6,523	-400 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.24 - $21.0 $4,496 - $8,400	400 New	400 $7,000

Others Institutions Holding BLUE

# of Institutions

142

Shares Held

63.2M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$121 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$82.1 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$36.7 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$36.6 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$30.1 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $605M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gerber Kawasaki Wealth & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Gerber Kawasaki Wealth & Investment Management with notifications on news.

Account